DE2213518A1 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
DE2213518A1
DE2213518A1 DE19722213518 DE2213518A DE2213518A1 DE 2213518 A1 DE2213518 A1 DE 2213518A1 DE 19722213518 DE19722213518 DE 19722213518 DE 2213518 A DE2213518 A DE 2213518A DE 2213518 A1 DE2213518 A1 DE 2213518A1
Authority
DE
Germany
Prior art keywords
active ingredient
acid
compound
butyltartronic
diphenylhydrazide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722213518
Other languages
German (de)
English (en)
Inventor
Paul R Dr Med Bock
Hans Gerd Eulenhoefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THIEMANN CHEM PHARM FAB
Original Assignee
THIEMANN CHEM PHARM FAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THIEMANN CHEM PHARM FAB filed Critical THIEMANN CHEM PHARM FAB
Priority to DE19722213518 priority Critical patent/DE2213518A1/de
Priority to FR7309467A priority patent/FR2182875B1/fr
Priority to GB1335773A priority patent/GB1409945A/en
Publication of DE2213518A1 publication Critical patent/DE2213518A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19722213518 1972-03-20 1972-03-20 Arzneimittel Pending DE2213518A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE19722213518 DE2213518A1 (de) 1972-03-20 1972-03-20 Arzneimittel
FR7309467A FR2182875B1 (enExample) 1972-03-20 1973-03-16
GB1335773A GB1409945A (en) 1972-03-20 1973-03-20 Pharmaceutical preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722213518 DE2213518A1 (de) 1972-03-20 1972-03-20 Arzneimittel

Publications (1)

Publication Number Publication Date
DE2213518A1 true DE2213518A1 (de) 1973-09-27

Family

ID=5839531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722213518 Pending DE2213518A1 (de) 1972-03-20 1972-03-20 Arzneimittel

Country Status (3)

Country Link
DE (1) DE2213518A1 (enExample)
FR (1) FR2182875B1 (enExample)
GB (1) GB1409945A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004058079A1 (de) * 2004-12-01 2006-06-08 Basf Ag Steigerung des Proteinanteils tierischer Organismen

Also Published As

Publication number Publication date
FR2182875B1 (enExample) 1976-07-02
FR2182875A1 (enExample) 1973-12-14
GB1409945A (en) 1975-10-15

Similar Documents

Publication Publication Date Title
CH640734A5 (de) Cerebralwirksames mittel.
US3634583A (en) Pharmaceutical composition for the treatment of oedematous conditions and hypertension
EP0529500B1 (de) Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
DE2625222C3 (de) 13-Dithiacyclopentan-2-ylidenmalonsäureester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3779842T2 (de) Antiallergisches mittel.
DE1964504C3 (de) Arzneimittel zur Behandlung ödematöser Zustände und Hypertensionen
DE2213518A1 (de) Arzneimittel
DE1902865A1 (de) Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2728589C3 (de) Verwendung von 2-(2,2-disubstituierten)-Äthylimidazolinen bei der Bekämpfung von Diabetes
WO2000056325A2 (de) Ibuprofen-lösung
DE1045599B (de) Verfahren zur Herstellung per os applizierbarer, protrahiert wirksamer Aminzubereitungen
DE2104851A1 (enExample)
DE1900772B2 (de) Salz aus N JS-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE2654518A1 (de) Neues phenaethylaminderivat, dessen salze und pharmazeutische zusammensetzungen
DE2919553A1 (de) Tetrahydroisochinolinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel
EP0178581B1 (de) Verwendung von 2-[(2-Brom-6-fluorphenyl)imino]imidazolidin als Sedativum
DE2636328A1 (de) Arzneimittel
DE2038836B2 (de) Arzneimittel
DE1928027C3 (de) 7-Chlor-6-fluor-4-chromanonoximmethyläther, Verfahren zu dessen Herstellung und diese Verbindung enthaltende pharmazeutische Zubereitungen
DE1467908A1 (de) Verfahren zur Gewinnung von Pacentamaterial
AT319463B (de) Röntgenkontrastmittel
DE2408372A1 (de) Pharmazeutische zubereitungen auf der grundlage von hippursaeurederivaten
EP0288072A2 (de) 3-(Amino)-4-äthylthio)-chinolin oder dessen Säureadditionssalze zur Verwendung als Arzneimittel und diese[s] enthaltende Arzneimittel

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination